How to Value a Dental Supply Company in 2026

Dental supply distribution sits in a strange competitive position. On one side, you have Henry Schein and Patterson Dental — two publicly traded giants that control roughly 70% of the market. On the other side, you have hundreds of independent and regional distributors that survive and sometimes thrive by offering something the big two can't: personalized service, local relationships, and the willingness to show up at a practice with an emergency order on a Saturday.

That competitive dynamic shapes every aspect of how these businesses are valued. Let me walk you through what buyers actually pay for dental supply companies and what makes one worth significantly more than another.

The Valuation Range: 4-7x EBITDA

Dental consumable supply distributors typically trade at 4-7x EBITDA. The range reflects enormous variation in customer stickiness, gross margins, and competitive positioning. A distributor with 400 active practice accounts, a proprietary ordering platform, and 28% gross margins is a fundamentally different business than one with 80 accounts, phone-and-fax ordering, and 19% margins.

The wholesale distribution sector generally trades at lower multiples than other healthcare services, and dental supply is no exception. Margins are thin, competition is fierce, and the threat of the big two is ever-present. But the right dental supply companies — the ones with deep practice relationships and genuine switching costs — command multiples that rival or exceed other distribution niches.

Practice Count: The Top-Line Metric

When a buyer evaluates a dental supply company, the first question is always: "How many active accounts?" This is the dental supply equivalent of same-store sales in retail. But count alone is meaningless without context.

What matters is revenue per practice per yearand the distribution of that revenue. An average dental practice spends $30K-60K annually on consumables — gloves, composites, impression materials, anesthetics, bonding agents, cements, endo files, and everything else that gets used and reordered. If your average account is spending $45K with you annually, you're likely their primary supplier. If they're spending $12K, you're a secondary source and vulnerable to displacement.

Buyers model customer quality in tiers:

• Primary accounts ($35K+/year): You're the main vendor. These accounts are sticky, high-margin, and form the core business value.
• Secondary accounts ($10K-35K/year): You're one of two or three suppliers. These have growth potential but lower switching costs.
• Occasional accounts (under $10K/year): Spot purchases, cherry-picking specific products. Minimal value in an acquisition context.

A company with 200 primary accounts is worth more than one with 400 accounts that are mostly secondary and occasional. Buyers know the difference, and they'll audit your account-level revenue data during due diligence.

Recurring Orders and Auto-Ship Revenue

Dental consumables are inherently recurring — practices reorder the same products every month. But there's a massive difference between revenue that recurs by habit and revenue that recurs by system.

The best dental supply companies have built ordering systems that create structural stickiness. Whether it's an auto-ship program where practices receive their standard consumable order monthly, an online portal where the practice's order history makes reordering effortless, or a field rep who physically manages inventory levels in the practice, these systems convert passive repeat purchasing into something closer to true recurring revenue.

Distributors with formal auto-ship programs covering 40%+ of revenue trade at the higher end of the range. This revenue is predictable, requires minimal sales effort to maintain, and has documented retention rates that buyers can underwrite. A company that relies entirely on inbound phone orders, where every purchase is a discrete decision, is valued lower because there's no systemic retention mechanism.

The Henry Schein and Patterson Problem

Every buyer of a dental supply company asks the same question: "What stops Schein or Patterson from taking these accounts?" If you don't have a convincing answer, your valuation suffers.

The independents that command premium multiples have built defensible positions through one or more of these strategies:

Service-level differentiation. The big two are massive organizations with corporate processes. An independent that offers same-day delivery in their metro area, provides emergency weekend orders, and has a rep who knows every practice by name offers something Schein fundamentally cannot. Practices pay a slight premium for that reliability.

DSO and group practice relationships.Independent distributors that have secured contracts with dental service organizations or multi-location group practices have recurring revenue tied to organizational relationships, not individual dentist preferences. A 50-location DSO contract is worth significantly more per dollar of revenue than 50 individual practice relationships because it's centrally managed and contractually bound.

Private label or exclusive product lines. Some independents have developed private label consumables or secured exclusive distribution rights for specific manufacturers. This creates a product-level moat — if a practice wants that specific composite or bonding agent, they can only get it from you.

What Kills Dental Supply Company Value

Margin erosion.If your gross margins have declined from 25% to 20% over three years because you've been cutting prices to compete with Schein's buying programs, buyers see a business in a margin squeeze. They'll project the trend forward and discount accordingly. Margin stability or expansion is critical to valuation.

Over-reliance on equipment sales.Capital equipment (chairs, imaging systems, sterilizers) generates lumpy, low-margin revenue that doesn't repeat predictably. If equipment is more than 20% of your revenue, buyers will separate the consumable business from the equipment business and value them independently — usually to your disadvantage.

Field rep dependency. If your top sales rep controls 40% of your practice relationships and has no non-compete, you have a massive risk. That rep could leave, join a competitor, and take those accounts. Buyers will either demand retention agreements or discount the multiple significantly. The employee retention impact on valuation is particularly acute in distribution businesses where relationships drive revenue.

No technology platform.Distributors still running on spreadsheets and phone orders in 2026 look antiquated. An e-commerce portal with order history, automated reorder suggestions, and practice-level analytics isn't a luxury — it's table stakes. The cost of building one post-acquisition gets deducted from the offer.

Maximizing Value Before a Sale

Push auto-ship adoption. Set a goal of converting 50%+ of your active accounts to some form of automated reordering. Offer a modest discount (3-5%) to incentivize enrollment. The impact on your valuation multiple will far exceed the margin give-up.

Pursue DSO and group practice contracts. Even winning 3-5 multi-location accounts transforms your revenue quality story. These contracts provide documented recurring revenue with defined terms that buyers can model with confidence.

Protect your gross margins.Resist the temptation to compete on price with Schein. Compete on service, convenience, and relationship. A practice isn't switching from their trusted local rep to save 2% on composites — but they might if you train them to be price-sensitive by leading with discounts.

Lock down your sales team. Put non-compete and non-solicitation agreements in place with every field rep. Implement a compensation structure that vests over time. Make it hard and expensive for a rep to walk with their accounts.

Build your technology stack.If you don't have an online ordering portal, build one. It doesn't need to compete with Amazon — it needs to make reordering convenient and capture purchasing data that proves account stickiness during due diligence.

The Bottom Line

Dental supply distribution is a scale business where the independents win on service and relationships. The companies that trade at 6-7x have figured out how to institutionalize those relationships through auto-ship programs, technology platforms, and contractual commitments. The ones stuck at 4-5x are still relying on personal relationships and phone orders. In a market dominated by two public giants, the path to premium valuation runs through making your revenue as predictable and defensible as possible.